Characterization of Biomolecules with Antibiotic Activity from Endophytic Fungi Phomopsis Species

Authors

  • Janko Ignjatović Department of Drug Analysis, University of Belgrade – Faculty of Pharmacy
  • Nevena Maljurić Department of Drug Analysis, University of Belgrade – Faculty of Pharmacy
  • Jelena Golubović Department of drug analysis University of Belgrade - Faculty of pharmacy
  • Matjaž Ravnikar Chair for Pharmaceutical Biology, Faculty of Pharmacy, University of Ljubljana
  • Miloš Petković Department of Organic Chemistry, University of Belgrade – Faculty of Pharmacy
  • Nika Savodnik Biotechnical Faculty, University of Ljubljana
  • Borut Štrukelj Chair for Pharmaceutical Biology, Faculty of Pharmacy, University of Ljubljana
  • Biljana Otašević Department of Drug Analysis, University of Belgrade – Faculty of Pharmacy

DOI:

https://doi.org/10.17344/acsi.2019.5389

Keywords:

Endophytic fungi, antibacterial activity, HPLC, GC-MS, NMR

Abstract

Recently, growing interest is devoted to investigation of bioactive secondary metabolites of endophytic fungi. Thus, as an extension to our previous achievements related to antimicrobial potential of endophytic fungi, Phomopsis species isolated from conifer needles was selected as appropriately promising natural source for drug discovery. Its dichloromethane and ethanol extracts considerably inhibited growth of Escherichia coli and Staphylococcus aureus. Moreover, the individual compounds of dichloromethane extract have been separated, collected and purified using semi preparative liquid chromatographic analysis and comprehensively characterized using mass spectrometry (MS) and nuclear magnetic resonance spectroscopy (NMR). Based on their antimicrobial activity and unique structural characteristics in comparison with well-established drugs from the same therapeutic category, two dominant compounds (Z)-(Z)-2-acetoxyprop-1-en-1-yl-3-(3-((E)-3,4-dihydroxypent-1-en-1-yl)oxiran-2-yl)acrylate (denoted as 325-3) and (Z)-(Z)-2-acetoxyprop-1-en-1-yl 3-(3-((E)-4-hydroxy-3-oxopent-1-en-1-yl)oxiran-2-yl)acrylate (denoted as 325-5) were recognized as valuable leading structures for future discovery of novel antibiotics.

Downloads

Published

15.06.2020

Issue

Section

Analytical chemistry